StockData
Eledon Pharmaceuticals, Inc. logo

Eledon Pharmaceuticals, Inc. (ELDN) stock

ELDNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$2.03+0.05 (+2.53%)

Close on Nov 18, 2026Market cap $164.96MP/E –Yield –

Eledon Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Eledon Pharmaceuticals's revenue for the twelve months ending Mar 31, 2017 was $0. For fiscal 2016 it was $0. The highest annual figure on record is $0 in fiscal 2012.

Annual revenue

PeriodPeriod endValueChange
FY2016Dec 31, 2016$0–
FY2015Dec 31, 2015$0–
FY2014Dec 31, 2014$0–
FY2013Dec 31, 2013$0–
FY2012Dec 31, 2012$0–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2017Mar 31, 2017$0–
Q4 FY2016Dec 31, 2016$0–
Q3 FY2016Sep 30, 2016$0–

More Eledon Pharmaceuticals figures

See a number that looks wrong?